Around the Net
Mylan Targeted In Two EpiPen Probes
- Associated Press, Thursday, November 10, 2016 8 AM
The maker of EpiPen emergency allergy injectors, under a microscope for repeatedly jacking up the price of the life-saving device, revealed it is a target of two price-related probes by federal agencies and has had its premises searched. The came after Mylan reported a third-quarter loss, mainly due to a settlement for overcharging the federal government.
